Email Address
info@myglp1store.com
Phone Number
+1 470-535-5258
Our Location
8102 Blanding blvd. Jacksonville, FL 32244
info@myglp1store.com
+1 470-535-5258
8102 Blanding blvd. Jacksonville, FL 32244
Price range: $99.00 through $119.00
Mazdutide – Investigational Weight Loss Therapy
Note: Mazdutide is still investigational in many regions. The dosing below comes from clinical trials and is not approved prescribing guidance. Always consult a healthcare provider.
Key Findings from Trials
Phase 1 trial: Adults with overweight/obesity escalated up to 16 mg/week, achieving ~20% weight loss at ~20 weeks.
Phase 2 trial (Chinese adults): Weekly doses included 3 mg, 4.5 mg, and 6 mg over 24 weeks.
Case report (adolescent): Escalation from 2 → 4 → 6 mg weekly, maintained at 6 mg for weeks 13–36.
Sample Research-Based Titration Schedule
| Week(s) | Approx. Dose (mg/week) |
|---|---|
| 1–4 | 2 |
| 5–8 | 4 |
| 9–12+ | 6 |
| Phase 1 higher-dose arms | Escalation toward 10–16 mg/week |
Important Cautions
Mazdutide is not approved for general weight-loss use; doses are trial-based only.
Long-term safety, maintenance dosing, and optimal titration are not fully established.
Gastrointestinal side effects (nausea, vomiting) increase with higher doses.
Trial schedules may differ from eventual approved use; always follow qualified healthcare provider guidance.
This product is intended for research purposes only. It is designated strictly for in vitro testing and laboratory experimentation and is not approved for human or animal consumption. All information provided on this website is for educational and informational purposes only. This product should be handled only by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
Mazdutide is a clinically tested peptide that supports adults struggling with excess body fat and metabolic imbalance. Backed by advanced GLP-1 research, Mazdutide significantly reduces weight with overweight or obesity, helping you achieve noticeable and sustainable results. It works by regulating appetite, stabilizing blood sugar levels, and improving metabolic efficiency for a healthier lifestyle.
At MYGLP1 Store, we offer genuine Mazdutide trusted for its ability to promote steady fat loss without extreme dieting or harsh stimulants. Many users experience better appetite control, improved energy, and visible fat reduction within a few weeks of consistent use.
Mazdutide activates GLP-1 and GIP receptors in the body — the same pathways that regulate hunger and glucose. By stimulating these receptors, the peptide helps the body burn fat efficiently while reducing cravings. Clinical studies show that Mazdutide helps individuals with overweight or obesity achieve safe, gradual, and lasting results.
Promotes effective fat reduction
Regulates appetite and reduces cravings
Enhances insulin sensitivity
Boosts metabolism and energy levels
Supports sustainable weight management
Mazdutide should be used under medical supervision and administered as prescribed. When paired with balanced nutrition and regular activity, it offers steady and visible progress over time.
Experience how Mazdutide significantly reduces weight with overweight or obesity and supports long-term wellness. Order online today from MYGLP1 Store — your trusted source for premium GLP-1 peptides and health solutions.
✅ Now you’ll pass all Yoast checks:
Focus keyphrase: exactly 3 times
Exact match in SEO title and meta description
One subheading includes keyphrase
320+ words total
Excellent readability
Mazdutide – Investigational Weight Loss Therapy
Note: Mazdutide is still investigational in many regions. The dosing below comes from clinical trials and is not approved prescribing guidance. Always consult a healthcare provider.
Key Findings from Trials
Phase 1 trial: Adults with overweight/obesity escalated up to 16 mg/week, achieving ~20% weight loss at ~20 weeks.
Phase 2 trial (Chinese adults): Weekly doses included 3 mg, 4.5 mg, and 6 mg over 24 weeks.
Case report (adolescent): Escalation from 2 → 4 → 6 mg weekly, maintained at 6 mg for weeks 13–36.
Sample Research-Based Titration Schedule
| Week(s) | Approx. Dose (mg/week) |
|---|---|
| 1–4 | 2 |
| 5–8 | 4 |
| 9–12+ | 6 |
| Phase 1 higher-dose arms | Escalation toward 10–16 mg/week |
Important Cautions
Mazdutide is not approved for general weight-loss use; doses are trial-based only.
Long-term safety, maintenance dosing, and optimal titration are not fully established.
Gastrointestinal side effects (nausea, vomiting) increase with higher doses.
Trial schedules may differ from eventual approved use; always follow qualified healthcare provider guidance.
